Social Media Sidebar

Announcement

Please sign up, comment on articles and bring your friends!

Current poll

PlanetTech is asking:

What do you think about our new web site?

Love it, indeed
Really good solution
Same as old one
The old one was better
This is a new option

Quote of the day

'By far the greatest danger of Artificial Intelligence is that people conclude too early that they understand it'

 

Eliezer Yudkowsky

Early signs that drug 'may delay Alzheimer's decline'

RATE THIS! +26
Posted in Science on 23rd Jul, 2015 12:14 AM by AlexMuller

Details of how a drug could slow the pace of brain decline for patients with early stage Alzheimer's disease have emerged. Data from pharmaceutical company Eli Lilly suggests its solanezumab drug can cut the rate of the dementia's progression by about a third. The results are being met with cautious optimism.

 

A new trial is due to report next year and should provide definitive evidence. The death of brain cells in Alzheimer's is currently unstoppable. Solanezumab may be able to keep them alive. Current medication, such as Aricept, can manage only the symptoms of dementia by helping the dying brain cells function.
 
But solanezumab attacks the deformed proteins, called amyloid, that build up in the brain during Alzheimer's. It is thought the formation of sticky plaques of amyloid between nerve cells leads to damage and eventually brain cell death.
 
Solanezumab has long been the great hope of dementia research, yet an 18-month trial of the drug seemingly ended in failure in 2012. But when Eli Lilly looked more closely at the data, there were hints it could be working for patients in the earliest stages of the disease.
 
It appeared to slow progression by around 34% during the study. So the company asked just over 1,000 of the patients in the original trial with mild Alzheimer's to take the drug for another two years. And positive results from this extension of the original trial have now been presented at the Alzheimer's Association International Conference.
 
They show those taking the drugs the longest had the most benefit. Dr Eric Siemers, from the Lilly Research Laboratories, in Indiana, told the BBC: "It's another piece of evidence that solanezumab does have an effect on the underlying disease pathology.
 
"We think there is a chance that solanezumab will be the first disease-modifying medication to be available."

Tags: brainAlzheimer'smemorydrugdementiaresearchhealthmedicine

Read original article » Back to category

Comments

Author: Guest
Posted: 2015-07-23
+1
Good news- however the fact that this drug only helps at earliest stages of dementia suggests that focus has to be on early diagnosis if treatment is to have any effect Reply
Author: Guest
Posted: 2016-05-06
+0
Areltics like this make life so much simpler. Reply


 

Recent headlines

  • Posted in Business on 2017-03-26 19:56:28
    The U.S. will be hit worse by job automation than other.....read more
    Posted in Business on 2017-03-26 19:49:51
    Elon Musk says Tesla will start taking orders for Solar.....read more
    Posted in Science on 2017-03-26 19:39:27
    Impact crater linked to Martian tsunamis..read more
    Posted in Software on 2017-03-25 14:13:38
    Google Develops A Deep Learning Machine That Could Learn.....read more
    Posted in Medicine on 2017-03-25 14:26:25
    Google’s Calico partners with new biotech firm to.....read more
Posted in Business on 2013-10-10 01:33
China is working towards a manned lunar mission in about.....read more
Posted in Business on 2013-10-20 07:17
Spacex says China is their main competitor for commercial.....read more
Posted in Software on 2013-10-20 06:43
Pirate Bay Browser Clocks 1,000,000 Downloads..read more
Posted in Medicine on 2013-10-10 02:10
Google reportedly investing hundreds of millions into new.....read more
Posted in Medicine on 2013-10-14 03:13
Endothelial Cells Can Repair and Regenerate Organs,.....read more
Posted in Science on 01.01.2010
Spacex says China is their main competitor for commercial.....read more
Posted in Science on 01.01.2010
Staring at Your Phone Could Be Making You Short Sighted..read more
Posted in Science on 01.01.2010
Oculus Rift virtual reality headset coming to mobile, but.....read more
Posted in Science on 01.01.2010
China is working towards a manned lunar mission in about.....read more
Posted in Science on 01.01.2010
Delivering drugs via nanoparticles to target mitochondria..read more

Recent Blog Posts

  • Posted by AlexMuller
    Intensive medical treatment can reverse type 2 diabetes..read more
    Posted by AlexMuller
    Daily consumption of tea protects the elderly from cognitive.....read more
    Posted by AlexMuller
    New analysis method of metabolites accurately predicts whether.....read more
    Posted by AlexMuller
    Unproven stem cell 'therapy' blinds three patients at Florida.....read more
    Posted by AlexMuller
    Indigenous South American group has healthiest arteries of all.....read more

Login to your Account

Login to your PlanetTech Account here

Username:
Password:
Remember me
or

Create a New Account

You just need username and password

The following errors occured:
Username:
Email:
Password:
Verify password:
Remember me